Related Experiment Video
Updated: Sep 26, 2025

A Free-breathing fMRI Method to Study Human Olfactory Function
Published on: July 30, 2017
Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis
Omid Mirmosayyeb1,2, Narges Ebrahimi2, Mahdi Barzegar1,2
1Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Background:
The importance and prevalence of olfactory dysfunction is recently gaining attention in patients with multiple sclerosis (MS) as a result of their chronic inflammatory disease, yet different prevalence rates are reported for it. Therefore, we have designed this systematic review to estimate the pooled prevalence of olfactory dysfunction in patients with MS. To our knowledge, this is the first systematic review and meta-analysis on the prevalence of olfactory dysfunction in MS patients.
Methods:
We searched PubMed, Scopus, EMBASE, Web of Science, ProQuest, and gray literature including references from the identified studies, review studies, and conference abstracts which were published up to January 2021. Articles that were relevant to our topic and could provide information regarding the prevalence of olfactory dysfunction, or the scores of smell threshold, discrimination, or identification (TDI) among MS patients and healthy individuals were included. The pooled prevalence was calculated using a random-effects model and a funnel plot and Egger's regression test were used to see publication bias.
Results:
The literature search found 1630 articles. After eliminating duplicates, 897 articles remained. Two conference abstracts were included for final analysis. A total of 1099 MS cases and 299 MS patients with olfactory dysfunction were included in the analysis. The pooled prevalence of olfactory dysfunction in the included studies was 27.2%. Also, the overall TDI score in MS patients was lower than that in the control group, and the level of Threshold, Discrimination, and Identification per se were lower in MS compared with control respectively.
Conclusion:
The results of this systematic review show that the prevalence of olfactory dysfunction in MS patients is high and more attention needs to be drawn to this aspect of MS.
Insights
Olfactory dysfunction, or impaired sense of smell, affects 27.2% of multiple sclerosis (MS) patients. This systematic review highlights the high prevalence of smell dysfunction in MS, urging greater clinical attention.
Area of Science:
- Neurology
- Ophthalmology
- Otorhinolaryngology
Background:
- Olfactory dysfunction is increasingly recognized in multiple sclerosis (MS) patients.
- Prevalence rates vary, necessitating a comprehensive analysis.
- This is the first systematic review and meta-analysis on this topic.
Purpose of the Study:
- To estimate the pooled prevalence of olfactory dysfunction in MS patients.
- To analyze smell function (TDI scores) in MS patients compared to controls.
Main Methods:
- Systematic review and meta-analysis of studies up to January 2021.
- Searched multiple databases (PubMed, Scopus, EMBASE, Web of Science, ProQuest) and gray literature.
- Calculated pooled prevalence using a random-effects model; assessed publication bias.
Main Results:
- Included 1099 MS cases from 897 articles and 2 conference abstracts.
- Pooled prevalence of olfactory dysfunction in MS patients was 27.2%.
- MS patients exhibited lower overall TDI scores, including Threshold, Discrimination, and Identification, compared to controls.
Conclusions:
- Olfactory dysfunction is highly prevalent in multiple sclerosis patients.
- This finding warrants increased clinical attention to olfactory issues in MS management.
- Further research may elucidate the mechanisms and implications of smell loss in MS.
Related Concept Videos
Olfactory Receptors: Location and Structure
Olfaction
The olfactory receptors are embedded in the cilia of the...
Physiology of Smell and Olfactory Pathway
The olfactory...

